Genor Biopharma Holdings Ltd 6998.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:08 PM CTT
1.25quote price arrow down-0.03 (-2.34%)
Volume
287,000
52 week range
0.85 - 2.00
Loading...
  • Open1.22
  • Day High1.26
  • Day Low1.19
  • Prev Close1.28
  • 52 Week High2.00
  • 52 Week High Date05/02/23
  • 52 Week Low0.85
  • 52 Week Low Date02/15/24

Key Stats

  • Market Cap83.8M
  • Shares Out512.53M
  • 10 Day Average Volume153,400
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change5.04

KEY STATS

  • Open1.22
  • Day High1.26
  • Day Low1.19
  • Prev Close1.28
  • 52 Week High2.00
  • 52 Week High Date05/02/23
  • 52 Week Low0.85
  • 52 Week Low Date02/15/24
  • Market Cap83.8M
  • Shares Out512.53M
  • 10 Day Average Volume153,400
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change5.04

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-0.85
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genor Biopharma Holdings Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.
Feng Guo Ph.D.
Executive Chairman of the Board, Chief Executive Officer
Wende Chen
Chief Operation Officer
Qibin Liang
Chief Technology Officer
Yao Chen
Vice President - Regulatory Affairs
Jun Lin
Vice President - Quality Analysis
Address
89 Nexus Way, Camana Bay,
P.O. Box 31106
Shanghai, SHA
201203
China